Mukes (Fluconazole)

Fluconazole, the active ingredient in Mukes, is an azole antifungal presented as an oral formulation for systemic use. It is employed to treat a range of fungal infections, including candidiasis, cryptococcal meningitis and other systemic mycoses, in adult and pediatric patients as directed by a healthcare professional.

GNH USA supplies Mukes as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch.

Fluconazole is used to treat fungal infections that involve the Candida species or systemic mycotic pathogens.

Candidiasis: reduces fungal burden and resolves mucosal or cutaneous lesions. Cryptococcal meningitis: achieves fungal clearance from the central nervous system. Systemic mycoses: controls dissemination of susceptible fungi in deep tissues.

Fluconazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset often reported. - Headache: transient cranial discomfort. - Diarrhea: loose stools. - Rash: skin redness or itching.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: life‑threatening allergic response. - QT prolongation: cardiac rhythm disturbance.

Before prescribing Mukes, clinicians should consider several safety measures. - Liver function: assess baseline hepatic enzymes before initiating therapy. - Renal function: adjust dose in patients with severe renal impairment. - Drug interactions: review concomitant medications that affect CYP2C9 or CYP3A4. - Pregnancy: avoid use unless benefits outweigh potential risks. - Hypersensitivity: discontinue if allergic reaction occurs. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Fluconazole interacts with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Warfarin: fluconazole can increase INR and risk of bleeding. - Ritonavir/strong CYP3A4 inhibitors: may raise fluconazole plasma levels. - Oral contraceptives: reduced efficacy leading to possible breakthrough bleeding.

Moderate Interactions (Monitor Closely): - Phenytoin: may lower fluconazole concentrations, reducing efficacy. - Carbamazepine: induces metabolism, potentially decreasing antifungal effect. - Statins (e.g., simvastatin): increased risk of myopathy due to elevated statin levels.